Spago Nanomedical AB (publ) (STO:SPAGO)
0.1330
-0.0050 (-3.62%)
May 21, 2026, 11:21 AM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 91.3 million as of May 21, 2026. Its market cap has increased by 38.00% in one year.
Market Cap
91.30M
Enterprise Value
65.37M
Revenue
4.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 91.30M, an increase of 96.58%. That is a compound annual growth rate of 5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 91.30M | 18.45% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Magle Chemoswed Holding AB | 119.55M |
| NextCell Pharma AB | 118.30M |
| IRLAB Therapeutics AB | 107.70M |
| Annexin Pharmaceuticals AB | 105.18M |
| AcouSort AB | 103.28M |
| Biovica International AB | 101.29M |
| Scandinavian ChemoTech AB | 92.91M |
| OncoZenge AB | 91.03M |